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Abstract
Background: Hepatic dysfunction and jaundice are traditionally viewed as late features of sepsis and portend poor
outcomes. We hypothesized that changes in liver function occur early in the onset of sepsis, yet pass undetected by
standard laboratory tests.
Methods and Findings: In a long-term rat model of faecal peritonitis, biotransformation and hepatobiliary transport were
impaired, depending on subsequent disease severity, as early as 6 h after peritoneal contamination. Phosphatidylinositol-3-
kinase (PI3K) signalling was simultaneously induced at this time point. At 15 h there was hepatocellular accumulation of
bilirubin, bile acids, and xenobiotics, with disturbed bile acid conjugation and drug metabolism. Cholestasis was preceded
by disruption of the bile acid and organic anion transport machinery at the canalicular pole. Inhibitors of PI3K partially
prevented cytokine-induced loss of villi in cultured HepG2 cells. Notably, mice lacking the PI3Kc gene were protected
against cholestasis and impaired bile acid conjugation. This was partially confirmed by an increase in plasma bile acids (e.g.,
chenodeoxycholic acid [CDCA] and taurodeoxycholic acid [TDCA]) observed in 48 patients on the day severe sepsis was
diagnosed; unlike bilirubin (area under the receiver-operating curve: 0.59), these bile acids predicted 28-d mortality with
high sensitivity and specificity (area under the receiver-operating curve: CDCA: 0.77; TDCA: 0.72; CDCA+TDCA: 0.87).
Conclusions: Liver dysfunction is an early and commonplace event in the rat model of sepsis studied here; PI3K signalling
seems to play a crucial role. All aspects of hepatic biotransformation are affected, with severity relating to subsequent
prognosis. Detected changes significantly precede conventional markers and are reflected by early alterations in plasma bile
acids. These observations carry important implications for the diagnosis of liver dysfunction and pharmacotherapy in the
critically ill. Further clinical work is necessary to extend these concepts into clinical practice.
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Introduction
Extrahepatic bacterial infection and the ensuing host inflam-
matory response (sepsis) account for approximately 20% of cases of
jaundice [1]. Hyperbilirubinaemia (bilirubin .34.2 mmol/l),
noted in 11% of critically ill patients, is a strong independent
risk factor for mortality [2]. This reflects cholestasis and parallels
an increase in serum bile acid levels in the late phase of the disease
[3]. Laboratory studies support the concept that more subtle
alterations occur at the hepatocellular level soon after the onset of
sepsis, and that these too may be prognostic [4,5].
Pathogen-associated molecular patterns trigger release of
cytokines and other inflammatory mediators by Kupffer cells,
resulting in a local inflammatory milieu [6]. Influx of polymor-
phonuclear neutrophils, representing a secondary damaging surge,
may critically augment the development of excretory dysfunction
[7,8]. These factors impact upon hepatocellular transport proteins,
notably the energy-dependent canalicular ATP-binding cassette
transporters required for normal bile secretion [9] that underlie
sepsis-associated cholestasis [10].
These hepatobiliary transport processes involved in bile
formation, also known as phase III biotransformation, frequently
require prior processing of hydrophobic or amphiphilic substrates.
This is achieved by cytochrome P450–dependent phase I
modifications that allow conjugation with various compounds
(e.g., glucuronic acid, sulfonates, glutathione, or amino acids) in
phase II biotransformation. Apart from their fundamental role in
the metabolism of endogenous compounds, these processes are
critical determinants of hepatic drug clearance [11]. Thus, altered
phase I, II, and III biotransformation may be a critical yet under-
appreciated aspect of liver damage in sepsis, where patients often
receive .20 different drugs daily [12].
Phosphatidylinositol-3-kinases (PI3Ks) constitute a family of
enzymes involved in intracellular signal transduction. The only
class IB member, PI3Kc, has an important role in a number of
immune processes and is considered a particularly promising
target for adjunctive treatment of (systemic) inflammation [13,14].
With regard to the physiological regulation of hepatobiliary
transport and bile secretion, PI3Ks are essential for intracellular
trafficking, selectively regulating ATP-dependent canalicular trans-
porters in both health and disease [15,16]. Failure of hepatobiliary
transport processes results in hepatocellular retention of bile acids,
with subsequent triggering of hepatocyte injury due to oxidative
stress, apoptosis/necrosis, and mitochondrial toxicity [17]. Al-
though PI3K signalling has received considerable attention in the
context of bile acid–mediated apoptosis, its role in hepatic phase I
and II metabolism of bile acids has not yet been addressed.
We thus hypothesized that the paradigm of excretory liver
dysfunction reflecting a late and uncommon event in sepsis
underestimates significant changes in biotransformation that involve
PI3K signalling. Using a rat model of polymicrobial sepsis in which
echocardiography was used to identify animals likely to die, we herein
uncover novel early markers of sepsis-induced liver dysfunction. The
systems biology approach applied within this study supports the
concept that, in addition to impaired active hepatobiliary transport,
key steps of phase I and II metabolism that crucially involve PI3K
signalling represent viable therapeutic targets.
Methods
Patient Samples
With approval from the ethics committees of the Jena
University Hospital and the Medical University of Vienna
(2160-11/07), plasma from 48 patients fulfilling standard criteria
for severe sepsis/septic shock was sampled on the day of diagnosis
and subjected to targeted metabolomic analysis in a prospective,
observational manner. Severe sepsis and septic shock were defined
according to published criteria [18]. Patients (n= 17 at Jena
University Hospital, and n= 31 at Vienna General Hospital) were
eligible for study enrolment if the onset of the syndrome was
,24 h prior to study inclusion. Written informed consent was
obtained from all patients or their legal representatives. For
patients in whom prior consent could not be obtained because of
critical illness or the use of sedative or anaesthetic drugs, a
surrogate decision maker was fully informed and gave consent.
Site investigators used standardised definitions to determine site of
infection, the clinical severity scores, and final outcome measures.
All patients received sepsis treatment for cardiovascular, respira-
tory, renal, and metabolic failure according to the guidelines of the
German Sepsis Society [19].
Rat Experiments
All animal procedures were approved by the local authorities
(Thuringian State Office for Consumer Protection and Food
Safety or the ethics committee of University College London) and
were conducted in accordance with UK Home Office guidelines
under the 1986 Scientific Procedures Act and with US National
Institutes of Health guidelines. Animals were maintained under
artificial day–night cycles (12 h light–dark cycles; 2361uC room
temperature, 30%–60% environment humidity), received a
standard rat diet and water ad libitum, and were allowed to
adapt to laboratory conditions for at least 3 d. All surgical
procedures were carried out under aseptic conditions after
application of local anaesthesia, while body temperature was
maintained at 37uC.
Under a brief period of inhalational anaesthesia, male Wistar
rats (12–16 wk old) received tunnelled right jugular vein and left
carotid artery catheters that were subsequently mounted onto a
swivel-tether system, allowing the rat, on recovery from anaesthe-
sia, to have unimpeded movement in its cage and free access to
food and water.
Twenty-four hours later, sepsis was induced by peritoneal
contamination and infection with a stool suspension, as previously
described [20,21]. Sham animals of similar age, gender, and
weight underwent identical instrumentation and fluid administra-
tion, but did not receive faecal slurry.
In previous experiments utilising transthoracic echocardiogra-
phy, 13 of 14 animals with a 6-h (post-insult) stroke volume
,0.17 ml died within 72 h (mortality 93%), compared with one of
five animals with a stroke volume $0.17 ml (mortality 20%,
p= 0.006). Hence, a 6-h stroke volume ,0.17 ml could prognos-
ticate 3-d mortality with high positive (93%) and negative (80%)
predictive values. Consequently, this cutoff value was used in
subsequent experiments to distinguish predicted survivors from
predicted non-survivors [22]. In these studies, at 6 h after
induction of sepsis, liver tissue was taken under terminal
anaesthesia for whole genome transcriptomic profiling.
Experiments focussing on protein expression, structural alter-
ations, and functional analysis were performed in both sham-
treated animals and animals subjected to lethal sepsis (achieved by
increasing the stool inoculum) [21] at 15 h post-insult to allow
changes to occur at the functional level and to reduce variability.
For determination of cumulative bile flow, groups of animals were
instrumented and treated identically, but with additional cannu-
lation of the choledochal duct. Biliary output of glutathione and
bile acids was determined as previously described [23]. For non-
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invasive, whole body near-infrared fluorescence imaging using
indocyanine green (ICG), separate groups of animals were
instrumented and treated identically but, in addition, were fed
with a specific manganese-reduced diet over a 4-wk period prior to
instrumentation because of the intrinsic near-infrared properties of
manganese. The whole body near-infrared fluorescence imaging
device (Maestro, Cri) was equipped with a 710- to 760-nm
excitation band pass and an 800-nm emission long pass filter,
enabling transcutaneous assessment of whole body ICG fluores-
cence. Fifteen hours after sepsis induction, native images were
taken, followed by administration of ICG (14 pmol/g body
weight). Fluorescence intensity was subsequently measured at 0,
30, 150, and 300 min post-injection. Animals were examined at
these time points under a brief period of isoflurane anaesthesia and
returned to their cages in between. After 300 min, animals
underwent laparotomy, and images were taken of the exposed
abdominal cavity. The liver was then excised and re-examined by
epifluorescence microscopy (AxioObserver Z1, Zeiss), as described
previously [24]. Overview images (506 magnification) were
generated with the DAPI filter set (365- to 395-nm excitation
and 445- to 450-nm emission band pass filters) and ICG filter set
(775- to 805-nm excitation and 845- to 855-nm emission band pass
filters) using an integrated multichannel mode. At least four
perivenous and four periportal areas per animal were further
analysed (2006 magnification) to assess regional relative pixel
intensities.
Hepatic microcirculation and NADH autofluorescence were
assessed in vivo 15 h post-insult using the inverted epifluorescence
microscope. Video sequences (five regions of interest per animal)
were recorded using 206objective lenses and the DAPI filter set.
Sinusoidal perfusion failure was determined by the number of
non-perfused sinusoids expressed as a percentage of all sinusoids.
Mouse Experiments
PI3Kc2/2 (12–16 wk) mice were derived by ten generations of
successive backcrosses of heterozygous male knockout mice from
chimeric C57BL6/129Sv PI3Kc2/2 mice [25] with C57BL/6
females (Jackson Laboratory). Polymicrobial sepsis was induced by
peritoneal contamination and infection, as described previously
[26]. Leukocyte–endothelium interactions in the liver were studied
6 h after the septic insult [21]. Briefly, esterase-positive leukocytes
were visualised by staining in vivo with 1 mg/kg carboxyfluor-
escein diacetate succinimidyl ester (Molecular Probes). Esterase-
positive leukocytes that migrated into the parenchyma were
counted in five regions per animal (106 objective lens) and are
indicated as leukocytes per square millimetre of liver surface area.
Primary and Cultured Hepatocytes
For freeze-fracture replica immunolabelling (FRIL) of multidrug
resistance-associated protein 2 (Mrp2), primary hepatocytes were
isolated from sham and septic rats by a two-step collagenase
perfusion method performed at 15 h. After inserting a portal
venous catheter, the liver was immediately flushed with a Ca2+-
free perfusion medium to remove erythrocytes and plasma
proteins. Subsequently, the liver was perfused with a collagenase
H (Roche)–containing perfusion medium oxygenated with carbo-
gen (95% O2, 5% CO2) at 37uC at a flow rate of 40 ml/min
(recirculating via backflow through the vena cava), followed by
various filtration and washing steps.
HepG2 cells for scanning electron microscopy were cultivated in
DMEM/F12 medium supplemented with 10% FCS at 37uC. For
either specific inhibition of PI3Kc or general inhibition of all PI3K
subtypes, cells were incubated with AS605240 (Alexis) at an end
concentration of 1 mM or wortmannin at an end concentration of
100 nM, respectively. After 1 h, a cytokine mix comprising TNF-a
(50 ng/ml), IL-1b (10 ng/ml), IFN-c (10 ng/ml), and LPS
(100 ng/ml; serotype 0111:B4) was added, and cells were
incubated for a further 6 h. Untreated cells and cells stimulated
with cytokine mix but no inhibitor served as controls.
For FRIL, HepG2 cells were scraped from the culture dish,
subsequently centrifuged at 15g for 5 min, frozen, and processed as
described for Mrp2 labelling of primary hepatocytes.
RNA Isolation and Genome-Wide Expression Profiling
Liver samples (30–50 mg) were homogenized in 900 ml of lysis
buffer from RNeasy Mini Kit (Qiagen) with the Qiagen tissue
lyser, and further processed following manufacturer’s instructions.
RNA was eluted with DEPC water, its concentration determined
by UV-spectrophotometry (Nanodrop), and its integrity verified by
denaturing RNA gel electrophoresis and analysis on a Bioanalyzer
platform (Agilent Technologies). After reverse transcription and
amplification of 200 ng of total RNA (Illumina RNA Amplifica-
tion Kit, Ambion), cRNA was quantified spectrophotometrically,
followed by hybridization of 750 ng of cRNA onto an Illumina
Sentrix RatRef-12 Expression BeadChip. Each array covers
22,523 rat gene targets based on RefSeq content, with each
feature represented on average 30 times. Streptavidin-coupled
Cy3 (FluoroLink Cy3, GE Biosciences) was used for staining.
Thereafter, arrays were washed, dried, and immediately scanned
on an Illumina BeadArray Reader.
Western Blot Analysis
Similar amounts of protein (50 mg) from microsomal, peroxi-
somal, or cytosolic fractions were separated by SDS-PAGE,
transferred to a PVDF membrane, and probed to bile acid-
Coenzyme A: amino acid N-acyltransferase (BAAT) (Santa Cruz
Biotechnology). Immune complexes were detected using ECL
Western HRP substrate (Millipore). Equal protein loading was
confirmed by re-probing the membranes for b-actin (Abcam).
Immunofluorescence Analysis of Transporter Expression
Frozen rat liver sections were stained for bile salt export pump
(Bsep) using rabbit anti-Bsep (1:100, provided by Bruno Stieger),
or double-stained overnight using a mixture of rabbit anti-Mrp2
(1:500, Sigma) and mouse anti-Na,K-ATPase (1:200, Abcam). The
sections were then washed and subsequently incubated for 2 h
with a mixture of Cy3 anti-rabbit IgG (1:100) and Cy5 anti-mouse
IgG (1:100) (both Jackson ImmunoResearch Laboratories). Neg-
ative controls were performed by omitting primary antibodies.
Pictures were taken on a confocal laser scanning microscope
(LSM510 META, Carl Zeiss). To compare the immunofluores-
cence intensity of different livers, instrument settings were kept
constant across the complete series of experiments.
Electron Microscopy (FRIL, Scanning Electron Microscopy,
Ultrathin Sections)
FRIL was performed using overnight incubation with a rabbit
polyclonal anti-MRP2 primary antibody (1:50) (M8316, Sigma),
followed by incubation with a gold-conjugated (10 nm of gold)
goat anti-rabbit IgG secondary antibody (1:50, British Biocell
International) for 1 h [27]. Images were taken as digital pictures
on an EM902A transmission electron microscope (Carl Zeiss)
using a 1k FastScan CCD camera (TVIPS).
For scanning electron microscopy, HepG2 cells grown on glass
coverslips were washed in 0.1 M (pH 7.2) sodium cacodylate
buffer (SCB), fixed with glutaraldehyde (2.5% in SCB) for 45 min
and post-fixed with osmium tetroxide (1% in SCB). Samples were
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then dehydrated by rising ethanol concentrations in a BAL-TEC
CPD 030 Critical Point Dryer (BAL-TEC) and gold sputter coated
(layer thickness 20 nm) in a SCD005 Sputter Coater (BAL-TEC).
Samples were examined in a LEO 1450VP scanning electron
microscope (Carl Zeiss) at 8 kV acceleration voltage and a working
distance of 6 mm using a secondary electron detector.
Ultrathin sections were prepared from liver biopsies fixed with
glutaraldehyde (2.5% in SCB) and osmium tetroxide (1% in SCB).
Samples were dehydrated in rising ethanol concentrations and
infiltrated with Araldite resin. Curing of the resin was performed
for 48 h at 60uC. Embedded samples were ultrathin-sectioned
with a LKB 8800A Ultratome III (LKB Produkter), picked onto
Formvar-coated grids and stained with lead citrate for viewing in
the transmission electron microscope (see above).
Laboratory Markers of Inflammation and Sepsis-
Associated Liver Injury and Cholestasis
For quantification of IL-6, MCP-1, and TNF-a in mice, a
commercially available flow cytometric bead array was used
according to the manufacturer’s instructions (Mouse Inflammation
Kit, BD Biosciences). Plasma samples of rats and mice were
analysed for markers of organ dysfunction and injury, including
total bilirubin, gamma-glutamyltransferase, and alanine amino-
transferase by an automated veterinary clinical chemistry analyser
(Fuji Dri-Chem 3500i and Poch-100iv-Diff, Sysmex).
Determination of ATP Content
ATP was extracted from 10-mg freeze-dried tissue samples by
homogenization in nine volumes of ice-cold 0.5 M perchloric acid.
After neutralising the supernatant with 3 M potassium phosphate
solution, the ATP concentration was determined by a luciferase-
based luminometric assay (ATPLite, PerkinElmer) and quantified
against a standard curve. The acidic protein pellet was then re-
solubilised in 0.1 N NaOH and used for determination of protein
content for standardisation of ATP content to tissue protein.
Phase I and II Model Reactions
Activities of all biotransformation reactions were assessed in
9,000g supernatants of liver homogenates in 0.1 M sodium
phosphate buffer (pH 7.4) (1:3 w/v) and referenced to the protein
content of this fraction. For assessment of rat CYP1A, CYP2A,
CYP2B, CYP2C, and CYP2E activity, ethoxycoumarin O-
deethylation was performed, determining the main metabolite 7-
hydroxycoumarin fluorometrically [28]. To measure CYP3A
activity, ethylmorphine N-demethylation was performed accord-
ing to the method of Klinger and Mu¨ller [29], determining the
reaction product (formaldehyde) photometrically. Glutathione-S-
transferase activity was determined by performing 1-chloro-2,4-
dinitrobenzene conjugation and measuring the resulting dinitro-
benzene-glutathione conjugate, GS-DNB, photometrically [30].
Bilirubin glucuronidation was also assessed photometrically, using
Burchell’s method [31].
Micro-Raman Spectroscopy
Images were recorded using the Raman spectrometer RXN1
(Kaiser Optical Systems) equipped with a 785-nm diode laser for
excitation and a Leica microscope as microprobe. Raman images
were recorded in serial mapping mode using a 1006/0.9 objective
with a step size of 2.5 mm and an 8-s exposure time per spectrum.
HoloGrams software (Kaiser Optical Systems) controlled data
acquisition, intensity normalisation, and wave number calibration.
Hyperspectral datasets were processed by vertex component
analysis. This linear spectral unmixing algorithm estimates the
number of pure substances (‘‘end-members’’), their spectral
signatures, and abundance fractions. The goal was to describe
all spectra by a linear combination of these end-members. Details
regarding Raman images from liver tissue sections have been
previously published [32].
Targeted Metabolomics
Frozen tissue samples were weighted into 2-ml Precellys tubes
equipped with ceramic beads (Peqlab Biotechnologie). A mixture
of ethanol/10 mM phosphate buffer 85:15 (v/v) was then added
to the tissue sample in a 1:3 ratio (w/v). The Percellys tubes and
contents were inserted into a homogenizer (Peqlab Biotechnolo-
gie) set with a figure-eight motion at 0–4uC, with the program
(frequency, cycles, cycle time, pause between cycles) set at
5,800 rpm, 3630 s, 25 s. After homogenization, the homoge-
nates were centrifuged at 18,000g at 2uC for 5 min. The resulting
supernatants were pipetted into cryovials (1.5 ml, Biozym) and
analysed immediately to avoid degradation. In brief, a mixture of
isotopic internal standards and a 20-ml sample volume of plasma
derived from either human or rodent sources or tissue superna-
tant after homogenization were placed together into a 96-well
format capture plate. Proteins were precipitated by addition of
200 ml of acetonitrile and centrifugation. Supernatants were
transferred onto a new filter plate with 7-mm filter spots, dried
down, and hydrolysed with 0.35 M KOH in 95% ethanol.
Metabolites were extracted with 100 ml of aqueous methanol. An
aliquot of 20 ml of extracted sample was injected into an API4000
QTrap tandem HPLC-MS/MS system (AB Sciex/MDS An-
alytical Technologies). Acquired analytical data were quantified
with Analyst 1.4.2 software (Applied Biosystems) and exported for
statistical analysis.
Statistics
In brief, analysis of microarray data was performed using R
software in combination with Bioconductor packages, and
included quality control and normalisation [33]. Statistical
significance was assessed by false discovery rate–adjusted p-
values from one-way ANOVA for each bead type [34].
Unsupervised k-means clustering was applied to group the bead
types with highly similar expression profiles, which were then
plotted in a heatmap. Results from k-means clustering were
based on a minimal intra-class clustering error obtained from
500 iterations for up to n = 10 clusters. The transformed log2
expression values of each transcript taken from the sham,
predicted sepsis survivor, and predicted sepsis non-survivor
groups were compared with those of a naı¨ve group, using a
cutoff of $2-fold down- or up-regulation as significantly
regulated. Transcripts regulated ,2-fold in all three groups
compared to naı¨ve animals were excluded. Additionally,
significant bead types were subjected to Ingenuity Pathway
Analysis software (Ingenuity Systems), disclosing probable
pathophysiologic inter-relationships associated with the expres-
sion pattern. The microarray experiment description file
according to the MIAME checklist is available on request.
All other data are presented as boxplots illustrating medians
within boxes from first quartile (25th percentile) to the third
quartile (75th percentile) and whiskers ranging from the 10th to
the 90th percentiles (extreme values are marked outside) or are
depicted for average sham or wild-type adjusted concentration
ratios. Differences between groups were analysed by non-
parametric Mann–Whitney U test or Kruskal–Wallis test followed
by Tukey’s or Dunn’s post-hoc analysis, as appropriate. A p-
value,0.05 was considered significant.
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Figure 1. Rat model allowing assessment of early changes in gene expression, and relationships to outcome. (A) Protocol for
instrumentation, induction of sepsis, echo-guided prognosis stratification, and tissue harvesting. (B) The heatmap displays expression profiles of 1,373
genes with significantly different expression levels among the naı¨ve, sham, predicted sepsis survivor, and predicted non-survivor groups (n= 4 per
group). k-Means clustering revealed four gene clusters with comparable behaviour. Associated colours represent variance-normalised expression for
individual genes: red colour intensity indicates a relative expression greater than the mean, blue indicates the opposite. (C) The transcripts identified
in (B) were analysed by Ingenuity Pathway Analysis to identify canonical pathways found to be up- or down-regulated in animals predicted to die.
Presented is a bar chart of the most statistically significant (corresponding to p-value) down-regulated (blue) and up-regulated (red) pathways
associated with poor prognosis. Numbers in parentheses represent the number of differentially regulated transcripts involved in a defined pathway.
doi:10.1371/journal.pmed.1001338.g001
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Results
Rat Sepsis Models
As a first step toward identifying molecular mechanisms of
incipient liver failure in septic rats, a model of faecal peritonitis
utilising echocardiography to predict 3-d mortality as early as 6 h
after sepsis insult was applied (Figure 1A). Overall 72-h mortality
in this model was 75%. For analysis of the functional implications
of the detected transcriptomic changes, a lethal sepsis model was
generated using higher volumes of stool suspension (Figure S1).
Early Changes in the Hepatic Transcriptome Are
Associated with Unfavourable Outcomes in Sepsis
Echocardiography-based prognostic stratification enabled
identification of early changes in the hepatic transcriptome
between predicted survivors and predicted non-survivors. Anal-
ysis of gene expression from septic survivors, non-survivors, and
naı¨ve and sham-treated animals (n= 4 per group) revealed 1,373
significantly altered transcripts (false discovery rate–adjusted p-
values,0.001) (Figure 1B). These were allocated to four clusters
by unsupervised k-means cluster analysis. ‘‘Sham up’’ and ‘‘sham
down’’ clusters represent transcripts related to anaesthesia and
instrumentation. ‘‘Sepsis up-regulated’’ and ‘‘sepsis down-regu-
lated’’ clusters depict changes in transcript abundance that were
specific for sepsis, with a significantly more pronounced
regulation in either direction in predicted non-survivors. In a
cluster-free approach, we compared the average log2 fold change
values from non-survivors to those from survivors (Figure S2A).
Contrast-filtering by 2-fold differences yielded 104 and 184 up-
and down-regulated genes, respectively, validating a subset of
sepsis-specific candidate genes obtained from clustering with
stringent filtering. Transcripts discriminating the predicted
outcome were changed in non-survivors by a higher amplitude
(linear fit: slope = 1.6).
Next, a detailed search was made for critical pathways that
could distinguish survivors from non-survivors. Ingenuity Pathway
Analysis revealed a common decrease in metabolic processes
related to amino acid and fatty acid metabolism, bile acid and
xenobiotic metabolism, and upstream transcriptional regulation by
nuclear receptors. These metabolomic processes also discriminated
for predicted outcome, including the primarily down-regulated
canonical pathway ‘‘bile acid biosynthesis’’ (Figure S2B). With
regard to up-regulated processes, non-parenchymal effector
functions including cytokine signalling and phosphate transfer
(by kinases) were mainly identified. With this approach, the most
statistically significant regulated pathways associated with poor
prognosis could be identified (Figure 1C). These involved down-
regulation of phase I, II, and III metabolism in both comparisons
(Figure S3). A full list of up- and down-regulated transcripts in the
sepsis-related clusters is shown as Table S1.
Lethal Sepsis Causes Severe Cholestasis with
Hepatocellular Accumulation of Bilirubin, and Failure to
Excrete Xenobiotics in the Perivenous Region
Having identified early and potentially dysfunctional signalling
cascades, we then characterised their contribution to the
development of organ failure in rats subjected to lethal sepsis by
extending the duration of sepsis to 15 h to allow development of
overt organ dysfunction (5–12 per group). Animals displayed
laboratory signs of severe cholestasis at 15 h after sepsis induction,
however only minimal increases in alanine aminotransferase and
gamma-glutamyltransferase, traditional markers of hepatocellular
injury, were observed (Table 1). Serum concentrations of total
bilirubin doubled in rats subjected to lethal sepsis compared to
sham-treated animals, while cumulative bile flow was reduced to
approximately 40% of normal. There was a concomitant
reduction of biliary output of bile acids and glutathione, or even
absence of the latter. As a reflection of potential mechanisms
underlying cholestasis in polymicrobial sepsis, impairments in
microvascular perfusion—denoted by a near 3-fold increase in the
number of non-perfused sinusoids (21.5% [interquartile range:
15.2–46.5] versus 8.5% [4.5–17.5], p,0.001, n= 8 per group) and
bioenergetic failure, with a significant decrease in ATP content
(4.3 nmol ATP/mg protein [3.1–5.6] versus 1.0 [0.7–1.1],
p= 0.006, n= 5 sham, n= 8 sepsis)—were observed despite
maintained NADH autofluorescence (10,685 arbitrary units
[9,667–12,433] versus 11,539 [10,857–25,589], p= not significant,
n= 8 per group).
Microvascular perfusion and energetic failure are likely
contributors to excretory dysfunction. Impaired blood flow
delivery due to sinusoidal shutdown reduces the basolateral
availability of ligands, while ATP depletion further accenuates
canalicular transport failure. Therefore, excretion of bilirubin,
representing clearance of an endogenous molecule, and ICG,
reflecting the fate of xenobiotics, was examined at the whole
organ, subacinar, and cellular levels to permit localisation of
excretory dysfunction. When we applied near-infrared whole body
imaging to sham animals, specific ICG fluorescence appeared in
the upper right abdominal quadrant (liver) 30 min after dye
Table 1. Assessment of markers for hepatocellular injury and sepsis-associated cholestasis at 15 h after infection.
Marker Units
Sham Median (25th; 75th
Percentile) Sepsis Median (25th; 75th Percentile)
Alanine aminotransferase (serum) U/l 28 (20.5; 39.5) 103.0* (33.0; 119.5)
Gamma-glutamyltransferase (serum) U/l 4 (1.0; 4.5) 11.5** (8.0; 17.3)
Total bilirubin (serum) mmol/l 6.8 (5.6; 8.1) 16.3** (12.0; 18.4)
Cumulative bile flow ml?kg21?min21 61.7 (50.9; 70.3) 22.8** (18.1; 34.4)
Glutathione (biliary) mol/l 1.9 (1.2; 2.5) n.d.**
Bile acids (biliary) mmol/l 29.2 (24.3; 45.8) 21.4* (18.3; 25.4)
Markers were assessed in serum or bile, as specified.
*p,0.05 or
**p,0.01 compared to sham; n = 12 animals for each condition.
n.d., not detectable.
doi:10.1371/journal.pmed.1001338.t001
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administration, and shifted towards the lower quadrants within the
5-h observation period. On laparotomy and exposure of the liver,
no remaining hepatic fluorescence was detectable. Instead, the dye
was entirely present within the duodenum, consistent with the
normal excretory route of ICG via bile without further enterohe-
patic recirculation (Figure 2A). By contrast, septic animals
manifested considerable hepatic accumulation of dye, with near-
absent fluorescence within the gut. Subsequent inspection of these
livers by epifluorescence microscopy revealed a significantly higher
amount of ICG in the area surrounding the central veins
(Figure 2B and 2C). Endogenous bilirubin was elevated in the
perivenous region, assessed using micro-Raman spectroscopy
(Figures 2D and 2E). Both bilirubin and ICG are excreted via
an Mrp2-dependent mechanism [35]; transcripts encoding Mrp2
were among those mRNAs that showed a strong association with
predicted outcome (Figures S3 and S4).
Polymicrobial Sepsis Impairs Canalicular Bile Acid and
Organic Anion Conjugate Transport Machinery
In view of the association between Mrp2 transcripts and
predicted outcome in sepsis, as well as functional data indicating
accumulation of bilirubin and ICG, we further characterised the
regulation of critical ATP-binding cassette bile acid and organic
anion transporters at the canalicular pole. Notably, expression of
Bsep at the transcript level remained unchanged in survivors,
while steady state concentrations of transcripts for Mrp2 and Bsep
were substantially decreased in non-survivors (Figure S4). Immu-
nofluorescence for Bsep within the canalicular membrane was
diminished at 15 h in rats subjected to lethal sepsis (Figure 3A).
Using confocal laser scanning and electron microscopy, the
qualitative distribution and localisation of Mrp2 was assessed in
sham and septic rat livers. Figure 3A illustrates the distinct
canalicular staining pattern of Mrp2 in control animals, with Mrp2
almost exclusively localised to the canalicular pole of the
Figure 2. Sepsis-induced excretory dysfunction, as visualised by accumulation of the xenobiotic indocyanine green and bilirubin.
(A) Non-invasive whole body near-infrared fluorescence imaging of ICG at 15 h after sepsis induction. Shown are representative images from sham-
treated animals (left panels) and animals subjected to lethal sepsis (right panels) for five biological replicates each. While ICG is eliminated via
hepatobiliary excretion into the duodenum within the 300-min observation period in sham animals, the dye accumulates in the livers of septic
animals, with an almost absence of fluorescence signal in the gut, as confirmed after laparotomy (lower panels). The dotted line divides upper and
lower abdominal quadrants for orientation. (B) Subsequent epifluorescence microscopic examination of liver surfaces at 300 min after ICG
administration in sham and septic animals. Stars indicate central veins (magnification 506, pseudo-coloured). (C) ICG fluorescence intensities around
central veins were significantly higher in septic compared to sham-operated animals (n= 4 animals/group, five perivenous and five periportal areas
per animal, *p= 0.031 compared to sham). (D) Representative micro-Raman images of tissue sections from liver sections obtained from sham-
operated and septic rats 15 h post-insult. In the livers of the septic rats, relative intensities of the bilirubin component are elevated in the perivenous
region (stars). In contrast, only minor local spots of accumulated bilirubin could be verified in livers of control animals. Scale bars: 50 mm. (E) Raman
spectrum of the bilirubin component (red trace) with crystalline bilirubin for comparison (black trace). Main spectral contributions of bilirubin are
resolved near 971, 1,229, and 1,606 cm21 (arrows at 971 and 1,229 cm21; high peak at 1,606 cm21).
doi:10.1371/journal.pmed.1001338.g002
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hepatocytes delineating the bile canaliculi. However, at 15 h after
induction of sepsis, this pattern became irregular and disrupted,
with fuzzy labelling of the canalicular membrane. Considerable
amounts of immunoreactive Mrp2 were recovered inside the cell.
These were seen as punctuate staining in the pericanalicular
region, consistent with localisation in putative subapical vesicular
compartments.
Electron microscopy on primary hepatocytes isolated from
sham and septic animals 15 h after sepsis induction confirmed the
observed (post-)translational changes, and provided additional
information about structural alterations and potential short-term
cholestasis-promoting mechanisms. While the cell surface of
control hepatocytes was densely covered with microvilli coated
with Mrp2 protein, the plasma membranes of hepatocytes from
septic rats had almost entirely lost their microvilli (Figure 3B). In
these cells, immunoreactive Mrp2 protein was predominantly
found in small vesicles of 200–400 nm diameter located closely
beneath the canalicular plasma membrane. Quantitative analysis
by counting the number of immunogold particles bound to Mrp2
per area coating the plane membrane revealed 8.7 versus 4.9
particles/mm2 in hepatocytes recovered from sham and septic
animals, respectively. As the microvilli are almost absent in septic
animal hepatocytes, only the density of gold particles in microvilli
(sham only) and subapical vesicles (sepsis only) was quantified. The
lower density of gold particles in septic hepatocytes (130.1
particles/mm2 on sham microvilli, 107.2 particles/mm2 in septic
vesicles) was consistent with an observed 30% decrease of
immunoreactive protein assessed by immunoblotting (data not
shown).
Altered Biotransformation of Endo- and Xenobiotics in
Sepsis
The altered hepatic gene transcripts relating to outcome in the
sepsis model included not only transporters but also cytochromes
crucial for phase I enzymes related to phase II detoxification
(Figures S3 and S4). As observed for active hepatocellular
transport, these processes also affect handling of endogenous
ligands, notably bile acids, as well as xenobiotics. Animals
subjected to lethal sepsis exhibited a bile acid pattern indicative
of a profound conjugation defect. The fraction of unconjugated
bile acids, particularly cholic acid (CA) and chenodeoxycholic acid
(CDCA), was significantly elevated in all three compartments, i.e.,
blood, hepatic tissue, and bile. Concentrations of glycine- and
taurine-conjugated bile acids were increased within the hepato-
cellular parenchyma, and significantly lower in bile fluid taken
from rats subjected to lethal sepsis (Figure 4A). The ratio of
unconjugated CA (as substrate) and its primary conjugation
products taurocholic acid (TCA) and glycocholic acid (GCA)
indicated a .8-fold increase of unconjugated over conjugated bile
acids within septic liver parenchyma, and a 32-fold increase in CA
Figure 3. Altered expression of canalicular bile acid and organic anion transporters in sepsis. (A) Distribution and localisation pattern of
Bsep and Mrp2 in livers obtained from control and septic rats using confocal microscopy. Na,K-ATPase was used to stain the basolateral plasma
membrane. Staining for Bsep revealed a substantial decrease in protein expression after sepsis induction. In sham-treated animals immunoreactive
Mrp2 delineates bile canaliculi. The Mrp2 staining pattern in septic rats is irregular, disrupted, and accompanied by recovery of Mrp2 inside the cell, as
shown by punctuate staining in the pericanalicular region. Lowermost panels represent merged pictures of Na,K-ATPase and Mrp2. Scale bar: 20 mm.
(B) Electron micrographs of freeze-fracture-immunolabelled Mrp2 protein in the plasma membrane of isolated hepatocytes at 15 h post-infection to
further study irregular staining observed in sepsis. The cell surface of sham-treated animals is densely covered with microvilli, visible as cross-
fractured stubs (stars). A lengthwise fracture of the microvilli membrane exposes a dense labelling with Mrp2 protein arranged in small clusters along
microvilli (white arrowheads). By contrast, hepatocytes isolated from septic animals exhibited a loss of microvilli, while Mrp2 was predominantly
found in vesicles located closely beneath the canalicular membrane (black arrowheads). The inset shows a top view of a bile canaliculus formed by
two adjacent hepatocytes (scale bar: 1 mm). Scale bars in upper and lower panels indicate 200 nm and 100 nm, respectively. EF, exoplasmic fracture
face; PF, protoplasmic fracture face.
doi:10.1371/journal.pmed.1001338.g003
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within bile (Figure 4B). Likewise, free CDCA was elevated in blood
and liver tissue compared to its conjugation products, and reduced
within bile. We next assessed steady state protein levels of BAAT
as the key enzyme facilitating conjugation of bile acids with either
taurine or glycine within the cytosolic and peroxisomal fractions.
Fractionation was performed to address the bimodal distribution
of BAAT to cytosol and to peroxisomes performing bile acid
conjugation after enterohepatic circulation or amidation of de
novo synthesised bile acids, respectively [36]. BAAT immunore-
active protein levels were diminished by approximately 60% and
40% within the cytosolic and peroxisomal fractions, respectively,
at 15 h after sepsis induction (Figure 4C and 4D).
To explore whether similar deficits in bile acid conjugation
occur in septic patients, we obtained plasma from 48 patients
fulfilling American College of Chest Physicians/Society of Critical
Care Medicine criteria for severe sepsis or septic shock on their
day of diagnosis. Clinical characteristics of these patients are
summarised in Table 2 and confirm the expected morbidity and
mortality (28-d mortality approximately 45%) and the typical
sources of sepsis, i.e., primarily pneumonia and abdominal
infections followed by blood stream and urinary tract infections.
Alterations in unconjugated and conjugated bile acids were
consistent with those seen in the rodent model; however, the
conjugation deficit remains elusive and requires further investiga-
tion, as conjugated bile acids were similarly increased (Figures 5A
and S5). In contrast to bilirubin, the increases of CDCA and
taurodeoxycholic acid (TDCA) on the day of diagnosis predicted
28-d mortality with high sensitivity and specificity (AUROC:
bilirubin: 0.59; CDCA: 0.77; TDCA: 0.72; CDCA+TDCA: 0.87)
(Figure 5B).
To delineate whether impairment of other biotransformation
processes important for drug pharmacokinetics exists, typical
phase I detoxifying, cytochrome P450–dependent, monooxygen-
ase functions and phase II conjugation activities were analysed in
liver homogenates taken from the rodent model (n= 5–8 per
group). Activities of rat CYP1A, CYP2A, CYP2B, CYP2C, and
CYP2E (as assessed by the ethoxycoumarin O-deethylation model
reaction) and CYP3A activity (as assessed by ethylmorphine N-
demethylation) were significantly impaired in animals subjected to
lethal sepsis compared to sham-treated animals (Figure 6A and
6B). Likewise, glutathione-S-transferase activity and bilirubin
glucuronidation, representing typical phase II conjugation reac-
tions, were similarly reduced (Figure 6C and 6D).
Unravelling PI3K as Key Molecular Switch of Sepsis-
Associated Cholestasis In Vitro
Since PI3Ks are crucial for the host response and for transporter
trafficking, and in view of the association between their (up-
)regulation and unfavourable outcomes (Figure 1C), this family of
signalling proteins was evaluated further for a mechanistic
explanation of sepsis-associated cholestasis.
Two complementary in vitro experiments were performed to
characterise the effect of PI3K on insertion/internalisation
processes of MRP2/pseudovilli in human hepatoblastoma cells
Figure 4. Polymicrobial sepsis causes deranged bile acid conjugation and transport. At 15 h after sepsis induction, plasma, liver tissue,
and bile were subjected to targeted metabolomics. Expression of BAAT, facilitating conjugation to taurine and glycine, was quantified by
immunoblotting. (A) The plot depicts median log2 fold changes of unconjugated as well as glycine- and taurine-conjugated bile acid in plasma, liver,
and bile, comparing septic to sham-operated rats (n= 12 per group, *p,0.05 or **p,0.01 compared to sham). (B) Conjugation index as a surrogate
for the observed conjugation defect reflected by the ratio of unconjugated bile acids CA and CDCA to the corresponding taurine (TCA and
taurochenodeoxycholic acid) and glycine (GCA and glycochenodeoxycholic acid) conjugates in plasma, liver and bile (ratio given as log2 fold change,
n= 12 per group). (C and D) Representative immunoblots of BAAT 15 h after sepsis induction in cytosolic (c) as well as peroxisomal (p) fractions, with
corresponding densitometric analysis (n= 5 for sham, n= 8 for sepsis; BAAT (c): *p= 0.002; BAAT (p): *p= 0.006 compared to sham). Densitomentric
values are normalised to b-actin. DCA, deoxycholic acid; GDCA, glycodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; GLCA, glycolithocholic
acid; GLCAS, glycolithocholic acid sulphate; GUDCA, glycoursodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; TLCA, taurolithocholic acid;
TLCAS, taurolithocholic acid sulphate; TUDCA, tauroursodeoxycholic acid; UDCA, ursodeoxycholic acid.
doi:10.1371/journal.pmed.1001338.g004
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(HepG2) under inflammatory conditions. Treatment of HepG2
cells with a mix of TNF-a, IL-1b, IFN-c, and LPS induced a
retrieval of pseudovilli that represents the equivalent for canalic-
ular microvilli formed by this cell line. While the ratio of cells with
pseudovilli to total cells was 0.47 in controls, this dropped to 0.16
in cytokine-mix-stimulated cells (Figure 7A and 7B). Non-specific
(Wortmannin) or specific (AS605240) inhibition of PI3Kc prior to
stimulation gave partial protection (Figure 7B).
FRIL of corresponding cells confirmed pseudovilli loss but
additionally revealed an 80% decrease of MRP2 protein on the
membranes of cells stimulated with cytokine mix. Pre-incubation
with AS605240 and Wortmannin significantly suppressed loss of
pseudovilli and membrane-bound Mrp2, suggesting a critical role
of PI3Kc in the control of the cytokine-induced internalisation
process (Figure 7C and 7D).
PI3Kc2/2 Mice Are Protected against Hepatic Neutrophil
Accumulation and Cholestasis despite an Enhanced
Cytokine Response
Given the partial protection of PI3K inhibition against retrieval
of pseudovilli in human hepatoblastoma cells, PI3Kc2/2 mice
were used to study canalicular microvilli integrity and concomitant
development of cholestasis in vivo (n= 3–9 per group).
At 6 h after sepsis induction, morphologic examination using
transmission electron microscopy revealed disrupted brush borders
with widened bile canaliculi in wild-type mice (Figure 8A). Small
subapical vesicles located beneath the canalicular plasma mem-
brane were observed in these animals. By contrast, brush borders
Figure 5. Plasma bilirubin and (un)conjugated bile acid levels in patients on the day of diagnosis of severe sepsis. (A) The plot depicts
median log2 fold changes of bilirubin (Bili), and unconjugated as well as glycine- and taurine-conjugated bile acid quantities in plasma of severely
septic patients (n= 48) fulfilling American College of Chest Physicians/Society of Critical Care Medicine consensus criteria compared to non-septic
controls (n= 20) (*p,0.05 compared to controls). (B) Receiver operating characteristics of bilirubin, CDCA, TDCA, or the combined performance of
CDCA+TDCA in predicting 28-d mortality. DCA, deoxycholic acid; GDCA, glycodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; GLCA,
glycolithocholic acid; GLCAS, glycolithocholic acid sulphate; GUDCA, glycoursodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; TLCA,
taurolithocholic acid; TLCAS, taurolithocholic acid sulphate; TUDCA, tauroursodeoxycholic acid; UDCA, ursodeoxycholic acid.
doi:10.1371/journal.pmed.1001338.g005
Table 2. Clinical characteristics of septic patients subjected to
targeted metabolomic analysis of bile acids.
Characteristic Units Value
Number of patients n 48
Age in years median (25th; 75th percentile) 64.5 (58.8; 73.5)
Gender male n (percent) 30 (62.5)
28-d survivor n (percent) 27 (56.3)
APACHE II median (25th; 75th percentile) 28.0 (21.8; 37.3)
SAPS II median (25th; 75th percentile) 59.0 (44.5; 77.0)
SOFA median (25th; 75th percentile) 11.0 (8.0; 14.0)
Site/Type of infection
Pneumonia n (percent) 25 (52.1)
Abdominal infection n (percent) 9 (18.8)
Primary bacteraemia n (percent) 6 (12.5)
Urosepsis n (percent) 5 (10.4)
Other n (percent) 3 (6.25)
APACHE II, Acute Physiology and Chronic Health Evaluation II; SAPS II, Simplified
Acute Physiology Score; SOFA, Sequential Organ Failure Assessment.
doi:10.1371/journal.pmed.1001338.t002
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in septic PI3Kc2/2 mice were well maintained (Figure 8A), and
this was paralleled by an absence of hyperbilirubinaemia
(Figure 8B).
Overall, in vivo protection in the PI3Kc2/2 mice was more
pronounced than the partial protection seen in cultured HepG2
cells. This is consistent with a contribution of cells other than
hepatocytes towards mediation of in vivo excretory dysfunction.
As neutrophils may be critical effectors of cholestasis [8,37], we
analysed neutrophil recruitment in this model using in vivo
microscopy. This facet of acute inflammation was specifically
inhibited in PI3Kc2/2 mice (Figure 8C). Absence of hyperbiliru-
binaemia and the inability of neutrophils to migrate into liver
tissue in the septic PI3Kc2/2 mice were seen, notwithstanding
higher levels of inflammatory cytokines (TNF-a and IL-6) and the
chemoattractant MCP-1 (Figure 8D–8F).
As our results supported the concept that loss of the transport
machinery reflects only one facet of sepsis-associated cholestasis,
and as an inflammation-mediated down-regulation of BAAT was
identified as the mechanism for impaired bile acid conjugation, we
Figure 6. Polymicrobial sepsis severely impairs the activity of enzymes responsible for phase I and II biotransformation. (A) Activities
of CYP1A, CYP2A, CYP2B, CYP2C, and CYP2E were assessed by ethoxycoumarin O-deethylation, while (B) CYP3A activity was quantified using the
ethylmorphine N-demethylation model reaction for phase I biotransformation. Glutathione-S-transferase activity (C) and bilirubin glucuronidation (D),
representing typical phase II conjugation reactions, were assessed by the model reaction 1-chloro-2,4-dinitrobenzene conjugation, resulting in the
formation of dinitrobenzene-glutathione conjugate (GS-DNB), or the Burchell method, respectively (n= 5 for sham, n= 8 for sepsis, *p= 0.004
compared to sham).
doi:10.1371/journal.pmed.1001338.g006
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further assessed BAAT and bile conjugation in wild-type and
PI3Kc2/2 mice.
Compared to septic wild types, BAAT expression was main-
tained in the peroxisomal fraction and increased in the cytosolic
fraction in PI3Kc2/2 mice 6 h after sepsis induction (Figure 8G
and 8H). Because of plasma levels of unconjugated CA and
CDCA, PI3Kc2/2 mice maintained the ability to conjugate bile
acids. This was most pronounced at 15 h, i.e., a time by which
organ failure was fully developed (Figure 8I).
Discussion
Jaundice is a clinical hallmark associated with a poor prognosis
in sepsis. However, as its development does not usually become
apparent in the clinical context until days after the onset of disease,
liver failure is traditionally considered a late manifestation of
sepsis-induced multiple organ failure. The experimental data
presented herein provide strong evidence that liver dysfunction
affecting both biotransformation and transport of endo- and
xenobiotics is an early and frequent event in sepsis, with subclinical
alterations occurring within hours of infection. Moreover, we
Figure 7. Stimulation of HepG2 cells with prototypical sepsis-associated mediators triggers internalisation of pseudovilli via PI3K
signalling. (A) Representative electron microscopic images of HepG2 cells subjected to non-specific (Wortmannin) or specific (AS605240) inhibition
of PI3Kc prior to stimulation with a mix of TNF-a (50 ng/ml), IL-1b (10 ng/ml), IFN-c (10 ng/ml), and LPS (100 ng/ml) for 6 h. Untreated and cytokine-
mix-stimulated cells served as controls. Arrowheads and the inset indicate pseudovilli, representing the equivalent for canalicular microvilli formed by
this cell line. Scale bars: 10 mm, inset scale bar: 5 mm. (B) For quantification, the ratio of cells carrying pseudovilli to the total number of cells within the
observation field was analysed (p,0.001, post-hoc test: *p,0.05 compared to control, #p,0.05 compared to cytokine mix, n= 9–13 fields of interest
per treatment). (C) Representative electron micrographs of freeze-fracture-immunolabelled Mrp2 transporters in the plasma membrane of HepG2
cells. Cells were treated as described in (A). Inset indicates a cluster of membrane-incorporated immunolabelled Mrp2 protein. Scale bars: 200 nm,
inset scale bar: 100 nm. (D) For quantification, Mrp2 particles were assessed and normalised to the protoplasmic fracture face area. (p,0.001, post-
hoc test: *p,0.05 compared to control, #p,0.05 compared to cytokine mix, n= 23–25 fields of interest per treatment).
doi:10.1371/journal.pmed.1001338.g007
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reveal PI3K as a key molecular switch for this series of cellular
events in sepsis-associated liver dysfunction.
We used clinically pertinent animal models of faecal peritonitis,
in which stroke volume measured 6 h post-sepsis could reliably
distinguish between eventual survivors and non-survivors with
high sensitivity and specificity [20]. This model is particularly
valuable since tissues are harvested at a time point reflecting early
(mal)adaptive changes, and when clinical severity is relatively mild
and still indistinguishable between survivors and non-survivors.
Genome-wide gene expression analysis combined with a
structured network knowledge-based approach enabled us to
study early changes in steady state transcript levels that were
associated with eventual death. Mediators involved in inflamma-
tory signalling showed a marked increase, principally indicating an
enhanced pro-inflammatory, ‘‘acute phase’’ signal derived from
both parenchymal and non-parenchymal cells. Simultaneously,
down-regulation of housekeeping metabolic functions affecting
primarily phase I and II metabolism and molecular transport/
phase III metabolism, but also of negative acute-phase reactants,
was observed. Of note, the intensity of regulation of gene
expression (in either direction) related to disease severity, with a
likelihood of death within 72 h being detectable as early as 6 h
post-insult. The consistent pattern differentiating survivors from
non-survivors points towards a maladaptive response in animals
that proceed to die, with transcript levels in eventual survivors
being similar to those in sham-treated animals. A similar
association of impaired biotransformation with outcome was
observed in mice with pneumococcal disease if pneumonia
progressed to sepsis [38]. In line with these findings, our present
clinical data are consistent with the concept that cholestasis reflects
Figure 8. PI3Kc2/2 mice are protected against hepatic neutrophil infiltration and cholestasis despite increased inflammatory
mediators. (A) Representative electron micrographs for morphologic assessment of bile canaliculi in liver tissue obtained from wild-type and
PI3Kc2/2 mice 6 h after sepsis induction. Stars indicate widened bile canaliculi with disrupted brush borders in wild-type mice. Small vesicles located
closely beneath the canalicular plasma membrane were observed in wildtype mice, indicative of subapical vesicles (arrowheads). By contrast, brush
borders of PI3Kc knock-out mice were well maintained. Scale bars: 1 mm. (B) Levels of total bilirubin in sham-operated and septic wild-type and
PI3Kc2/2 animals (p,0.001, post-hoc test: *p,0.001 wild-type sham versus wild-type sepsis, #p= 0.008 wild-type sepsis versus knock-out sepsis;
n= 7–9 per group). (C) Assessment by intravital microscopy of infiltrating esterase-positive leucocytes per square millimetre of liver surface in wild-
type and PI3Kc2/2 mice at 6 h under sham or septic conditions (p,0.001, post-hoc test: *,#p,0.05 wild-type sham versus wild-type sepsis, as well as
wild-type sepsis versus knock-out sepsis; n= 3 animals per group with five regions of interest per animal). (D–F) Mean levels of TNF-a, IL-6, and MCP-1
from wild-type and PI3Kc-deficient mice at 6 h under sham and septic conditions (p,0.001, post-hoc test: #p,0.001 for wild-type sham versus wild-
type sepsis, knock-out sham versus knock-out sepsis and wild-type sepsis versus knock-out sepsis; n= 7–9 per group). (G and H) Representative
immunoblots of BAAT 6 h after sepsis induction in cytosolic (c) and peroxisomal (p) fractions, with corresponding densitometric analysis (n= 4 each
for wild-type and PI3Kc2/2 samples). Densitomentric values are normalised to b-actin. (I) Conjugation index reflected by the ratio of unconjugated
bile acids CA and CDCA to the corresponding taurine (TCA and taurochenodeoxycholic acid [TCDCA]) and glycine (GCA and glycochenodeoxycholic
acid [GCDCA]) conjugates in plasma of wild-type and PI3Kc2/2 mice at 6 and 15 h (ratio given as log2 fold change, n= 5–7 animals/group).
doi:10.1371/journal.pmed.1001338.g008
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a more generalised response to life-threatening infection and is not
restricted to peritonitis, as a similar accumulation pattern of bile
acids was observed in the largest subset of included patients
presenting with pneumonia.
The orchestrated reprogramming of the transcriptome to
infection implies a differential regulation of transcription factors.
Coordinated repression of critical nuclear receptors (FXR, RARa,
CAR, and PXR) is seen during the acute-phase response (Figure
S3). This tallies with prior evidence from endotoxin challenge
models [39,40]. These data confirm and extend previous studies
that identified pathways altered by sepsis [41], and additionally
determine those transcriptomic changes related to outcome.
To explore the functional implications and underlying cellular
mechanisms of cholestasis and altered biotransformation in the
animal model, we studied phase I and II biotransformation and
transport at 15 h post-insult. Use of this time point enabled
transcriptional changes to be manifest at both protein and
functional levels. A substantial degree of excretory dysfunction
was noted, despite only mild-to-moderate hepatocellular injury
consistent with clinical manifestations seen in the critically ill
[10,42]. A substantial increase in plasma bile acids in early sepsis,
which was also consistently seen in the patient samples, prompted
us to examine changes in the transporter machinery.
The canalicular conjugate export pump Mrp2 is critically
involved in the functional measures of cholestasis [43] including
excretion of bilirubin and glutathione and its conjugates, and the
disposition of divalent bile acids. Our data indicate a substantial
functional impairment of this transporter, as reported in rodent
endotoxemic models [44,45]. We noted a severity-related decrease
in mRNA and protein for Bsep, the rate-limiting transporter for
bile acids, whereas Mrp2 showed a decrease in transcripts in
prognosticated non-survivors (Figure S4). However, at 15 h, there
was only a moderate decrease in the membrane fraction of Mrp2
protein. In parallel, sizable amounts of Mrp2 were localised within
cells close to the canalicular pole. This trafficking implies
mobilisation predominantly of canalicular transporters that reside
within subapical endosomal pools, but also a reverse pathway
resulting in retrieval of transporters from the canalicular mem-
brane due to stimuli such as endotoxin, cytokines, or oxidative
stress [46].
Simultaneous withdrawal of microvilli and related transporters
from the canalicular membrane suggests substantial alterations to
the cytoskeleton. This could include disruption of microtubules
and derangement of actin microfilaments in the pericanalicular
region, with subsequent loss of microvilli and diminished
contractility of the canalicular membrane [47]. These changes
are consistent with a PI3K-mediated effect. With the data
indicating up-regulation of this critical cellular regulator, we were
prompted to study the functional role of PI3K in mediating post-
translational alterations in biliary transport. We used ICG as a
xenobiotic model substance to gain functional insights into
excretory dysfunction. Typically, transcellular ICG transport is
microtubule-dependent. Decreased binding of ICG to ligandin(s)
due to intracellular accumulation of bilirubin glucuronides may
contribute to the impaired ICG excretion seen in Mrp2-deficient
hyperbilirubinaemic rats [48]. The distribution and storage of
ICG into organelles (‘‘deep compartments’’) seen in these rats is
consistent with the observed ICG accumulation seen in the septic
rats in our study. Failure of canalicular excretion is reflected in the
accumulation of both the dye and endogenous bilirubin around
the central veins (Figure 2B and 2C), and consistent with the fact
that inflammation-induced down-regulation of canalicular trans-
porters, especially Mrp2, is most pronounced in pericentral
hepatocytes [49]. Excretory dysfunction may pave the way for
accumulation of xenobiotics requiring metabolism in pericentral
hepatocytes, i.e., the region prone to injury in the critically ill.
Drugs routinely administered to critically ill patients have poorly
understood pharmacokinetics, and concerns regarding their safety
and toxicity are increasing [50]. Altered xenobiotic metabolism
may further contribute to organ injury. For example, single-dose
administration of atorvastatin to septic patients resulted in supra-
therapeutic (up to 100-fold) plasma concentrations for up to 20 h
[51]. Apart from impaired hepatobiliary transport, a defect in
phase I detoxification machinery, including the cytochrome P450
enzymes predominantly involved in xenobiotic biotransformation
(i.e., P450 family CYP1, CYP2, and CYP3) and phase II
conjugating enzymes (glutathione-S-transferases, bilirubin-UDP-
glucuronyltransferase), would result in non-detoxification of
substances that are normally bile-excreted. In a cohort of septic
children, antipyrine clearance, measuring the detoxifying proper-
ties of several CYP enzymes, was reduced by 70% [52].
Impaired phase I and II metabolism was similarly present in
septic rats when we analysed biotransformation of bile acids.
Septic animals exhibited a profound defect in bile acid conjuga-
tion. This key result can be explained by reduced protein levels of
BAAT, which facilitates bile acid conjugation. Lack of side chain
conjugation may have profound impacts on bile acid distribution
(e.g., through cholehepatic shunting within the liver, further
contributing to elevated serum bile acid levels) and signalling (e.g.,
through altered affinity to dedicated G protein–coupled and
nuclear receptors) [53]. The present results as well as other recent
data [3] indicate bile acid accumulation on the day of diagnosis of
sepsis in the absence of hyperbilirubinaemia, and a persistent
pattern of increase in bile acids and bilirubin, in those patients who
proceed to die [3]. Unlike bilirubin levels, the observed early
increase in bile acids predicted 28-d outcome.
Our studies reveal PI3K as a key molecular switch for several
major cellular events in sepsis-associated excretory liver dysfunc-
tion. Sepsis-induced cholestasis crucially involves neutrophil
migration via P-selectin-mediated recruitment [8,37]. Migration
into liver tissue was completely prevented in PI3Kc2/2 mice.
Neutrophil and macrophage chemotaxis is mediated by a wide
variety of PI3Kc-dependent factors, and PI3Kc is also involved in
selectin-mediated capture and rolling, integrin-mediated adhesion,
and leukocyte extravasation [14]. Thus, PI3Kc represents a
promising target to alleviate sepsis-associated cholestasis
[16,54,55].
Both hydrophobic and hydrophilic bile acids can activate PI3K.
Effects range from cell survival to cell death, a phenomenon
termed the ‘‘PI3K paradox’’ [54]. While glycochenodeoxycholic
acid and taurolithocholic acid represent the main hydrophobic bile
acids exhibiting potent necrotic/apoptotic and cholestatic effects,
most hydrophilic bile acids (e.g., TCA and tauroursodeoxycholic
acid) promote cell survival, enhancement of bile flow, and
restoration of liver function in cholestasis [56]. A deficit in the
conjugation process, as demonstrated in the present study, results
in further accumulation and potential cytotoxicity of unconjugated
bile acids [57–59]. In contrast to septic wild-type mice, PI3Kc2/2
mice maintained the ability to conjugate bile acids, implying an
additional influence of PI3Kc on phase I and II bile acid
metabolism. Despite higher levels of circulating cytokines, BAAT
expression in hepatocytes was preserved or increased in PI3Kc2/2
mice 6 h post-sepsis compared to wild-type septic controls,
suggesting that BAAT may be a downstream target of PI3Kc
signalling.
Taken together, our findings challenge the current clinical
paradigm that cholestasis reflects an infrequent and late event in
sepsis. Strong evidence from the provided animal data support the
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concept that impaired biotransformation of bile acids (the most
prominent endogenous substrates for phase I, II, and III
biotransformation machinery) is a consistent and reproducible
finding that develops within hours after the onset of sepsis, predicts
adverse outcome, and may even represent a therapeutic target.
These changes critically depend upon PI3K activity as a molecular
switch. Diagnostic tests with superior sensitivity and specificity to
reflect altered biotransformation and hepatobiliary transport, as
well as novel biomarkers to identify disturbed pharmacokinetics in
the critically ill, are required. On a long-term basis, PI3K
signalling in sepsis-associated liver dysfunction may offer a
promising therapeutic target.
Supporting Information
Figure S1 Kaplan-Meier survival analysis of both
applied rat sepsis models. (A) Depicted are survival curves
for the lethal sepsis model (black line; n= 14), for the survivable
sepsis model (grey line; n= 19), and for sham-treated animals
(dotted line; n= 14). Log-rank statistic indicates a significant
difference between all survival curves (p,0.001). (B) In this
survival analysis only the non-survivors (n= 14) in the prognosis-
stratified sepsis model are included. Log-rank statistic indicates no
significant difference between the survival curves of both sepsis
models.
(TIF)
Figure S2 Scatterplot and top ten enriched canonical
pathways for the average disparity of transcripts in
predicted non-survivors as opposed to predicted survi-
vors. (A) Average log2 fold change for all 11,988 detected
transcripts. Red dots: up-regulated more than 2-fold in predicted
non-survivors compared to predicted survivors (n= 104). Blue dots:
down-regulated more than 2-fold in predicted non-survivors
compared to predicted survivors (n= 184). The linear fits for all
log2 fold change values exhibit higher amplitudes of expression
changes for predicted non-survivors (slope = 1.633). (B) Biplot of
top enriched results from Ingenuity Pathway Analysis for the input
set of corresponding transcripts (coloured as in [A]). False
discovery rate–adjusted p-values after Benjamini-Hochberg (B–
H, right axis) were computed using Fisher’s exact test accounting
for the number of hits, the number of uniquely mapped gene IDs
(n= 260), and the total number of entities in the defined pathway
(indicated on top of each bar).
(TIF)
Figure S3 Ingenuity Pathway Analysis of cellular events
discriminating predicted non-survivors from predicted
survivors. The canonical pathway of biotransformation gener-
ated with Ingenuity Pathway Analysis software using data from the
clusters ‘‘sepsis up-regulated’’ and ‘‘sepsis down-regulated’’ in the
heatmap depicts altered transcripts and presumed interactions of
the encoded proteins. Coloured molecules (red = up-regulated;
green = down-regulated, red/green = differential regulation of
isoforms) represent regulated transcripts. While genes involved in
inflammatory signalling (i.e., interleukin-1 receptor [IL-1R] and
TNF receptor-associated factor 2 [Traf2]) were up-regulated, the
majority of genes participating in cellular metabolic functions
showed steady state transcript levels that were substantially
decreased in prognosticated septic non-survivors as compared to
predicted survivors. Transcript levels encoding critical nuclear
receptors, such as farnesoid X receptor (FXR), retinoic acid
receptor-a (RARa), constitutive androstane receptor (CAR), and
pregnane X receptor (PXR), were coordinately down-regulated.
Genes involved in downstream processes responsible for phase I/II
metabolism (i.e., cytochrome P450 [CYPs], sulfotransferases
[SULTs], and glutathione-S-transferases [GSTs]) and phase III
transport (Mrp2, Na+-taurocholate cotransporting polypeptide
[Ntcp], and organic anion transporting polypeptides [Oatps]) of
endobiotic as well as xenobiotic compounds were affected, with a
decreased gene expression associated with poor prognosis.
(TIF)
Figure S4 Disease severity–dependent changes of tran-
scripts involved in phase I/II bile acid metabolism and
transport. The figure depicts log2 transformed fluorescence units
of critical transcripts encoding proteins involved in bile acid
biosynthesis and transport—including CYP7a1 (cholesterol-7-
alpha-hydroxylase), CYP27a1 (sterol 27-hydroxylase), BAAT,
Ntcp (Na+-taurocholate cotransporting polypeptide), Bsep (bile
salt export pump), and Mrp2—that were regulated according to
disease severity.
(TIF)
Figure S5 Raw data of bilirubin and unconjugated,
glycine-, and taurine-conjugated bile acids stratified
according to 28-d outcome. Bilirubin levels are compared to
reference control value (21 mmol/l). The number of detected
analytes is given below each boxplot. Significance of differences for
survivors versus control (*p,0.05, **p,0.01) and non-survivors
versus control (#p,0.05; ##p,0.01) is provided below the analyte
symbol.
(TIF)
Table S1 Full list of up- and down-regulated transcripts
out of cluster 1 and 3 for the comparison of predicted
non-survivors with predicted survivors.
(DOC)
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Editors’ Summary
Background. Sepsis (blood poisoning)—a life-threatening
condition caused by an inappropriate immune response to
an infection—is a major global cause of death. Normally,
when bacteria or other microbes enter the human body, the
immune system efficiently destroys the invaders. In sepsis
the immune system goes into overdrive, and the chemicals it
releases into the blood to combat the infection trigger
widespread inflammation (swelling). This leads to the
formation of small blood clots and leaky blood vessels that
block the flow of blood to vital organs such as the kidneys
and liver. In the most severe cases, multiple organs fail and
the patient dies. Anyone can get sepsis, but people with
weakened immune systems, the very young, and the elderly
are most vulnerable. Symptoms of sepsis include fever, chills,
rapid breathing, a fast heart rate, and confusion. In its early
stages, sepsis can be treated with antibiotics alone, but
people with severe sepsis need to be admitted to an
intensive care unit where the vital organs can be supported
while the infection is treated.
Why Was This Study Done? Thirty to fifty percent of
people who develop severe sepsis die. If sepsis could be
diagnosed in its early stages, it might be possible to save
more people. Unfortunately, the symptoms of sepsis mimic
those of other conditions, and, because sepsis tends to
develop very quickly, it is often not diagnosed until it is too
late to save the patient’s life. The development of liver
(hepatic) dysfunction and jaundice are both regarded as late
features of sepsis (jaundice is yellowing of the skin and eyes
caused by a build-up of bilirubin in the blood). However, the
researchers hypothesized that changes in liver function
occur early in sepsis and could, therefore, be used to
improve the diagnosis and management of sepsis.
What Did the Researchers Do and Find? The researchers
induced sepsis in rats by injecting bacteria into the
peritoneal cavity (the gap between the abdominal wall and
the abdominal organs), separated the infected animals into
predicted survivors and non-survivors based on their heart
stroke volume measured using cardiac ultrasound, and then
examined their liver function. The expression of genes
encoding proteins involved in ‘‘biotransformation’’ and
‘‘hepatobiliary transport’’ (the processes that convert waste
products and toxic chemicals into substances that can be
conjugated to increase solubility and then excreted) was
down-regulated within six hours of sepsis induction in the
predicted non-survivors compared to the predicted survi-
vors. Functional changes such as bilirubin and bile acid
accumulation in the liver (cholestasis), poor excretion of
xenobiotics (molecules not usually found in the body such as
antibiotics), and disturbed bile acid conjugation were also
seen in predicted non-survivors but not in survivors.
Moreover, phosphatidylinositol-3-kinase (PI3K) signaling
(which is involved in several immune processes) increased
soon after sepsis induction in non-survivor but not in
survivor animals. Notably, mice lacking the PI3Kc gene did
not develop cholestasis or show impaired bile acid conjuga-
tion after induction of sepsis. Finally, in human patients,
plasma bile acids were increased in 48 patients on the day
that severe sepsis was diagnosed, and these increases
accurately predicted death in these patients.
What Do These Findings Mean? These findings show
that liver dysfunction is an early event in animal models of
sepsis and that PI3K signalling plays a crucial role in the
development of liver dysfunction. They show that all
aspects of liver biotransformation are affected during sepsis
and suggest that outcomes are related to the severity of
these changes. The limited clinical data included in this
study also support the hypothesis that changes in liver
function occur early in sepsis, although these data need
confirming and extending. Taken together, these findings
suggest that liver function tests might aid early diagnosis of
sepsis and might also provide information about likely
outcomes. They also have important implications for the
use of drugs in patients who are critically ill with sepsis, in
that some of the drugs routinely administered to such
patients may not be adequately detoxified and may,
therefore, contribute to organ injury. Finally, these findings
suggest that inhibition of PI3Kc may alleviate sepsis-
associated cholestasis.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001338.
N This study is further discussed in a PLOS Medicine
Perspective by John Marshall
N The US National Institute of General Medical Sciences has a
fact sheet on sepsis
N The UK National Health Service Choices website has
information about sepsis and about jaundice
N The Surviving Sepsis Campaign, which was developed to
improve the management, diagnosis, and treatment of
sepsis, provides basic information about sepsis
N The Sepsis Alliance, a US not-for-profit organization, also
provides information about sepsis for patients and their
families, including personal stories about sepsis
N The not-for profit UK Sepsis Trust is another useful source
of information about sepsis that includes patient stories
N MedlinePlus provides links to additional resources about
sepsis and jaundice (in English and Spanish)
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